Investor

New Fortress Energy Inc. Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call

Retrieved on: 
Wednesday, January 19, 2022 - 9:15pm

New Fortress Energy Inc. (NASDAQ: NFE) (the "Company") plans to announce its financial results for the fourth quarter and full year 2021 prior to 8:00 A.M. Eastern Time on Tuesday, March 1st, 2022.

Key Points: 
  • New Fortress Energy Inc. (NASDAQ: NFE) (the "Company") plans to announce its financial results for the fourth quarter and full year 2021 prior to 8:00 A.M. Eastern Time on Tuesday, March 1st, 2022.
  • A copy of the press release and an earnings supplement will be posted to the Investors section of the Company's website, www.newfortressenergy.com.
  • In addition, management will host a conference call on Tuesday, March 1st, 2022 at 8:00 A.M. Eastern Time.
  • A simultaneous webcast of the conference call will be available to the public on a listen-only basis at www.newfortressenergy.com.

WHIRLPOOL CORPORATION TO ANNOUNCE FOURTH-QUARTER RESULTS ON JANUARY 26 AND HOLD CONFERENCE CALL ON JANUARY 27

Retrieved on: 
Wednesday, January 19, 2022 - 9:05pm

Whirlpool Corporation will then hold a conference call to discuss its performance with the investment community at 8 a.m.

Key Points: 
  • Whirlpool Corporation will then hold a conference call to discuss its performance with the investment community at 8 a.m.
  • To participate in the conference call, dial 1 (888) 440-4038 and Conference ID 2610251. International participants should dial 1 (646) 960-0861 and Conference ID 2610251.
  • Participants should dial in at least 10 minutes prior to the call, as they may experience longer than usual wait times.
  • Whirlpool Corporation (NYSE: WHR) is committed to being the best global kitchen and laundry company, in constant pursuit of improving life at home.

MFDA Hearing Panel issues Reasons for Decision (Penalty) in the matter of King Kwong Clement Chow

Retrieved on: 
Wednesday, January 19, 2022 - 8:31pm

TORONTO, Jan. 19, 2022 /CNW/ A Hearing Panel of the Prairie Regional Council of the Mutual Fund Dealers Association of Canada ("MFDA") has issued its Reasons for Decision (Penalty) dated January18,2022 ("Reasons for Decision"), in connection with a penalty hearing held electronically by videoconference on August 25, 2021, in the matter of King Kwong Clement Chow ("Respondent").

Key Points: 
  • TORONTO, Jan. 19, 2022 /CNW/ A Hearing Panel of the Prairie Regional Council of the Mutual Fund Dealers Association of Canada ("MFDA") has issued its Reasons for Decision (Penalty) dated January18,2022 ("Reasons for Decision"), in connection with a penalty hearing held electronically by videoconference on August 25, 2021, in the matter of King Kwong Clement Chow ("Respondent").
  • In its Reasons for Decision, the Hearing Panel confirmed the sanctions imposed on the Respondent.
  • A copy of the Reasons for Decision (Penalty) is available on the MFDA website at www.mfda.ca .
  • During the period described in the Reasons for Decision (Penalty), the Respondent conducted business in the Edmonton, Alberta area.

MFDA Hearing Panel issues Reasons for Decision in the matter of John Hillsdon

Retrieved on: 
Wednesday, January 19, 2022 - 8:18pm

TORONTO, Jan. 19, 2022 /CNW/ - A Hearing Panel of the Central Regional Council of the Mutual Fund Dealers Association of Canada ("MFDA") has issued its Reasons for Decision dated January 18, 2022 ("Reasons for Decision"), in connection with a settlement hearing held electronically by videoconference in Toronto, Ontarioon December 15, 2021, in the matter of John Hillsdon (the "Respondent").

Key Points: 
  • TORONTO, Jan. 19, 2022 /CNW/ - A Hearing Panel of the Central Regional Council of the Mutual Fund Dealers Association of Canada ("MFDA") has issued its Reasons for Decision dated January 18, 2022 ("Reasons for Decision"), in connection with a settlement hearing held electronically by videoconference in Toronto, Ontarioon December 15, 2021, in the matter of John Hillsdon (the "Respondent").
  • In its Reasons for Decision, the Hearing Panel confirmed the sanctions imposed on the Respondent.
  • A copy of the Reasons for Decision is available on the MFDA website at www.mfda.ca .
  • During the period described in the Reasons for Decision, the Respondent conducted business out of the Markham, Ontario area.

The Pink Bot: A Powerful New Tool to Buy & Sell Crypto Coins

Retrieved on: 
Tuesday, January 18, 2022 - 12:15pm

New York, New York--(Newsfile Corp. - January 18, 2022) - Expert team creates The Pink Bot to buy and sell new crypto coins faster, safer, and automatically.

Key Points: 
  • New York, New York--(Newsfile Corp. - January 18, 2022) - Expert team creates The Pink Bot to buy and sell new crypto coins faster, safer, and automatically.
  • After the "Okay to Buy" confirmation, clicking the "Buy Tokens" button is all that is required to begin.
  • The Pink Bot will complete the purchase as soon as the presale or launch begins, and can be verified on BSCscan.
  • The Pink Bot brings speed, scam protection, and automation into the world of cryptocurrency, which makes it one of the most powerful crypto tools ever created for retail investors.

Success Financial Team Announces Support of Compassion International

Retrieved on: 
Wednesday, January 19, 2022 - 6:00pm

The management at Compassion International ensure the provision of the following basic life necessities to children from unfortunate backgrounds;

Key Points: 
  • The management at Compassion International ensure the provision of the following basic life necessities to children from unfortunate backgrounds;
    According to Success Financial Team , there are many causes out there that are worth supporting through both words and actions.
  • Compassion International is striving to eliminate the detrimental effects of poverty on individuals, families, children, and the community as a whole and, according to the team at Success Financial Team, their efforts in this regard are commendable.
  • Since the beginning of the pandemic, many donors have limited their financial support to charitable organizations due to financial complications.
  • For more information on Success Financial Team, visit www.successfinancialteam.com or send an email to info@successfinancialteam.com .

Outlook Therapeutics to Present at the Virtual Investor 2022 Top Picks Conference

Retrieved on: 
Wednesday, January 19, 2022 - 1:05pm

As part of the virtual event, Outlook Therapeutics will provide a corporate presentation, followed by a moderated interactive Q&A session.

Key Points: 
  • As part of the virtual event, Outlook Therapeutics will provide a corporate presentation, followed by a moderated interactive Q&A session.
  • Interested parties may also pre-submit questions in advance of the live event, which can be sent via the conference website at virtualinvestorco.com.
  • A live video webcast of the presentation will be available on the Events page of the Investors section of Outlook Therapeutics website (outlooktherapeutics.com) .
  • Outlook Therapeutics expects to submit ONS-5010 ophthalmic bevacizumab to the U.S. FDA as a BLA under the PHSA 351(a) regulatory pathway.

AIM ImmunoTech to Present at the Virtual Investor 2022 Top Picks Conference

Retrieved on: 
Wednesday, January 19, 2022 - 1:35pm

J.D., Chief Executive Officer of AIM, will present at the Virtual Investor 2022 Top Picks Conference on Wednesday, January 26, 2022 at 10:00 AM ET.

Key Points: 
  • J.D., Chief Executive Officer of AIM, will present at the Virtual Investor 2022 Top Picks Conference on Wednesday, January 26, 2022 at 10:00 AM ET.
  • As part of the virtual event, the Company will provide a corporate presentation, followed by a moderated interactive Q&A session.
  • Interested parties may also pre-submit questions in advance of the live event, which can be sent via the conference website at virtualinvestorco.com .
  • A webcast replay will be available two hours following the live presentation and will be accessible for one year.

InterDigital Announces Date for Fourth Quarter and Full Year 2021 Financial Results

Retrieved on: 
Wednesday, January 19, 2022 - 1:30pm

WILMINGTON, Del., Jan. 19, 2022 (GLOBE NEWSWIRE) -- InterDigital, Inc. (NASDAQ:IDCC), a mobile and video technology research and development company, today announced that the company will release its fourth quarter and full year 2021 financial results before market open on Thursday, February 17, 2022.

Key Points: 
  • WILMINGTON, Del., Jan. 19, 2022 (GLOBE NEWSWIRE) -- InterDigital, Inc. (NASDAQ:IDCC), a mobile and video technology research and development company, today announced that the company will release its fourth quarter and full year 2021 financial results before market open on Thursday, February 17, 2022.
  • InterDigital executives will host a conference call that same day at 10:00 a.m. Eastern Time (ET) to discuss the company's financial performance and other company matters.
  • For a live Internet webcast of the conference call, visit www.interdigital.com and click on the link to the live webcast on the Investors page.
  • InterDigital is a registered trademark of InterDigital, Inc.

Fight Colorectal Cancer Launches its Plan to Find a Cure

Retrieved on: 
Tuesday, January 18, 2022 - 7:40pm

Springfield, Mo., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Today, Fight Colorectal Cancer (Fight CRC), the nation's leading patient advocacy organization, revealed its Path to a Cure Report for colorectal cancer (CRC).

Key Points: 
  • Springfield, Mo., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Today, Fight Colorectal Cancer (Fight CRC), the nation's leading patient advocacy organization, revealed its Path to a Cure Report for colorectal cancer (CRC).
  • This project brings together many of the thought leaders in the colorectal cancer community who are passionate about accelerating research and improving outcomes for colorectal cancer patients.
  • Their legacy gifts enabled Fight CRC to host the first annual Path to a Cure Think Tank in Springfield, Mo.
  • We want to take this plan to Capitol Hill and show members of Congress that this is what we will do with the funds they allocated for colorectal cancer research, said Molly McDonnell, Director of Advocacy at Fight Colorectal Cancer.